Amundi
MRNA icon

Amundi’s Moderna MRNA Stock Holding History

Amundi’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.2M Sell
888,779
-16,044
-2% -$830K 0.02% 567
2026
Q1 		$46M Sell
904,823
-238,790
-21% -$11.1M 0.01% 613
2025
Q4 		$33.7M Buy
1,143,613
+127,558
+13% +$3.47M 0.01% 715
2025
Q3 		$28M Buy
1,016,055
+106,626
+12% +$2.97M 0.01% 670
2025
Q2 		$27.5M Sell
909,429
-425,861
-32% -$11.2M 0.01% 655
2025
Q1 		$34.4M Buy
1,335,290
+129,017
+11% +$4.58M 0.01% 606
2024
Q4 		$52.1M Buy
1,206,273
+535,273
+80% +$25.6M 0.02% 550
2024
Q3 		$39.2M Sell
671,000
-64,429
-9% -$5.92M 0.01% 592
2024
Q2 		$85.3M Buy
735,429
+87,840
+14% +$11.1M 0.03% 411
2024
Q1 		$66.1M Sell
647,589
-106,771
-14% -$10.8M 0.03% 467
2023
Q4 		$83.1M Buy
754,360
+187,810
+33% +$15.8M 0.04% 426
2023
Q3 		$55.7M Buy
566,550
+1,788
+0.3% +$199K 0.03% 488
2023
Q2 		$68.7M Sell
564,762
-148,048
-21% -$19.7M 0.03% 448
2023
Q1 		$110M Sell
712,810
-94,499
-12% -$15.6M 0.06% 336
2022
Q4 		$151M Buy
807,309
+67,000
+9% +$11M 0.08% 260
2022
Q3 		$93M Buy
740,309
+447,693
+153% +$67.9M 0.06% 354
2022
Q2 		$46.8M Buy
292,616
+68,334
+30% +$9.77M 0.04% 455
2022
Q1 		$35.7M Sell
224,282
-308,463
-58% -$51.9M 0.02% 534
2021
Q4 		$112M Buy
532,745
+55,228
+12% +$16.1M 0.07% 299
2021
Q3 		$184M Buy
477,517
+32,977
+7% +$12.2M 0.13% 188
2021
Q2 		$104M Buy
+444,540
New +$79.4M 0.07% 285

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Amundi's MRNA Position: Q2 2026 in Review

Amundi reduced its Moderna (MRNA) stake by 1.8% in Q2 2026, selling an estimated $830K and leaving 888,779 shares worth $62.2M. The position accounts for 0.02% of the portfolio, ranked #567.

Amundi first reported a position in MRNA in Q2 2021 and has held it in 21 quarters since. The position peaked at $184M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Amundi held 888,779 shares of Moderna worth $62.2M as of Q2 2026.
  • Amundi sold 16,044 Moderna shares in Q2 2026, an estimated $830K.
  • Moderna made up 0.02% of Amundi's portfolio in Q2 2026, its #567 holding.
  • Amundi first reported a position in Moderna in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Moderna position peaked at $184M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.